Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2003
09/11/2003US20030171415 Strokes; cardiovascular disorders; mixture of melmisartan and ramipril
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171403 Blockade of voltage dependent sodium channels
09/11/2003US20030171401 Insertion drug delivery device containing fentanyl
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171395 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171389 Anticancer agents; bone disorders; antiarthritic agents
09/11/2003US20030171385 Synergistic enhancement of cognitive ability
09/11/2003US20030171384 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
09/11/2003US20030171381 Therapy for Parkinson's disease; antidepressants; antiepileptic agents
09/11/2003US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
09/11/2003US20030171365 Inhibitors of the interleukin-1beta conversion enzyme; useful in treatment of inflammatory, auto-immune and neurodegenerative diseases
09/11/2003US20030171360 Piperidines
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171357 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/11/2003US20030171356 Methods for alzheimer's disease treatment and cognitive enhancement
09/11/2003US20030171355 For modulating the activity of a G-protein-coupled receptor or a sigma receptor in a mammal; for treating inflammatory pain, neuropathic pain, multiple sclerosis, anxiety, depression, psychosis, stroke, motor neuron disease
09/11/2003US20030171353 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
09/11/2003US20030171331 Oxazolidinone cotherapy
09/11/2003US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD),
09/11/2003US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
09/11/2003US20030171302 Opioid derivative
09/11/2003US20030171300 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary
09/11/2003US20030171291 Novel treatment
09/11/2003US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030171266 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
09/11/2003US20030171255 Modulating the phosphorylation of DARPP-32 in a serotonergic receptor intracellular signaling pathway. The invention provides methods and compositions for modulating the activities of DARPP-32, casein kinase 1 (CK1),
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170812 Interleukin-1beta converting enzyme like cysteine protease
09/11/2003US20030170785 CDNA encoding the human alpha2 delta4 calcium channel subunit
09/11/2003US20030170685 Canine hepatocyte growth factor
09/11/2003US20030170651 Method of identifying a polymorphism in CYP2D6
09/11/2003US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression
09/11/2003US20030170331 Plant extract of the olea europaea as no-synthase inhibitor and uses
09/11/2003US20030170305 Sustained release over an extended period of time without an initial burst release of the agent(s) upon administration; outer layer of biodegradable polymer and inner portion of microcapsules formed from biodegradable polymer
09/11/2003US20030170304 Delivers an active ingredient in a pulsed or bimodal manner.
09/11/2003US20030170295 Hydrogel composition for transdermal drug delivery
09/11/2003US20030170292 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
09/11/2003US20030170289 Injectable depot compositions and uses thereof
09/11/2003US20030170275 Such as pain, mental disorders such as schizophrenia and stress-related disorders such as depression using, especially, M. vaccae material.
09/11/2003US20030170212 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
09/10/2003EP1343013A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents.
09/10/2003EP1342787A2 Arachidonic acid and methods for the production and use thereof
09/10/2003EP1342723A1 Indole derivatives and use thereof in medicines
09/10/2003EP1342718A1 Method and reagents for n-alkylating ureides
09/10/2003EP1342717A1 Benzimidazole derivatives
09/10/2003EP1342489A1 Method of affecting sleep and sleep-related behaviors
09/10/2003EP1342472A1 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid
09/10/2003EP1342410A2 Transgenic animals lacking a functional galanin gene
09/10/2003EP1342085A2 Non-apoptotic forms of cell death and methods of modulation
09/10/2003EP1341921A2 Hydrolases
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341795A2 Novel labeled resiniferatoxin derivatives
09/10/2003EP1341793A2 Crf receptor antagonists and methods relating thereto
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341786A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
09/10/2003EP1341783A1 Isoquinoline derivatives useful in the treatment of cns disorders
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341779A2 Heterocyclic sulfonamide inhibitors of beta amyloid production
09/10/2003EP1341778A1 Klainetin and derivatives thereof, method for their production and the use of the same
09/10/2003EP1341768A1 Therapeutic benzimidazole compounds
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341765A1 Therapeutic compounds
09/10/2003EP1341764A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341552A2 Treatment of immune-mediated diseases by oral administration of plasma fractions
09/10/2003EP1341548A2 METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY $g(b)-AMYLOID PEPTIDES
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1341536A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
09/10/2003EP1341531A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis
09/10/2003EP1341530A1 Use of a dopamine agonist with a short half-life for treating illnesses which can be treated by dopaminergic means
09/10/2003EP1181030B1 Tanacetum parthenium extract
09/10/2003EP1159237B1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/10/2003EP1150657B1 SPRAY CONTAINING UBIQUINONE Qn
09/10/2003EP1137644B1 Benzofuran derivatives, their preparation and use
09/10/2003EP1135389B1 1,4-diazabicyclo 3.2.2]nonane derivatives, their preparation and therapeutic application
09/10/2003EP1131321B1 Indole derivatives and their use as serotonin receptor ligands
09/10/2003EP1127871B1 New esters derived from substituted phenyl-cyclohexyl compounds
09/10/2003EP1047449B1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
09/10/2003EP0991650B1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003EP0851862B1 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders
09/10/2003CN1441811A Anti-body capable to selectively detect prion PrPsc isoforms
09/10/2003CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds
09/10/2003CN1441795A Method for preparation of citalopram
09/10/2003CN1441791A 四唑衍生物 Tetrazole derivative
09/10/2003CN1441788A Novel arylethene-sulfonamides compounds
09/10/2003CN1441787A Modulators of TNF-alpha signaling
1 ... 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 ... 1833